Electronic Laboratory Notebook

Mövenpick Hotel, Berlin, Germany

24 - 26 September, 2013


  • facebook
  • linkedin
  • twitter

ELNs Download Centre

Featured Download

PDFPDF

  • The Future of the Connected Lab: Features vs. IntegrationThe Future of the Connected Lab: Features vs. Integration
    In this exclusive Pharma IQ Interview Michael Elliott, CEO, Atrium Research and Eva-Lotta Westberg, Program Manager, AstraZeneca, discuss what vendors could be doing better to support interoperability, features vs. integration and the biggest challenges for an integration project. Westberg also shares key lessons learnt from embarking on an integration project and her future insights for the connected lab.
  • ELNs, Data Analytics, Knowledge Management: Trends, Challenges & OpportunitiesELNs, Data Analytics, Knowledge Management: Trends, Challenges & Opportunities
    The need to effectively utilize the data and apply knowledge management is being discussed in the boardroom, but how are you reacting to these changes and how will they impact the future? To find out Pharma IQ conducted a survey and produced this one page infographic, in association with ELNs, Data Analytics and Knowledge Management Summit

Podcasts

  • The Genentech ELN story

    Spending less time on paperwork is a goal for all companies and the pharmaceutical industry is no different. In this Pharma IQ recording, John Trigg, Director, phaseFour Informatics caught up with Martin Vanderlaan, Director of Analytical Operations at Genentech, to discuss Genentech's recent ELN rollout in bioprocess development, a relatively new environment for ELNs.  

  • The Future of the Connected Lab: Features vs. Integration

    In this exclusive Pharma IQ Interview Michael Elliott, CEO, Atrium Research and Eva-Lotta Westberg, Program Manager, AstraZeneca, discuss what vendors could be doing better to support interoperability, features vs. integration and the biggest challenges for an integration project. Westberg also shares key lessons learnt from embarking on an integration project and her future insights for the connected lab.


  • How To: Scalable Unique Device Identification (UDI) Implementation – Real World Lessons Learnt

    In this exclusive interview Dawn Fowler, Sr. Manager, Labeling & Documentation at Endologix, speaks to Andrea Charles from Pharma IQ, about the importance of real world assessment in executing UDI programs and reveals scalable ways to implement unique identifiers for medical devices.

    Fowler also shares her top 3 tips for implementing UDI Information on a medical device and insights into the common pitfalls manufacturers make when they are just setting out.


  • Array's ELN: Maturing into the Teenage Years

    Array Biopharma was one of the first pharmaceutical organisations to implement an ELN 11 years ago. Cat Andersen and the team at Array have been instrumental to ensuring its sucess. She spoke to Pharma IQ about the secret behind a successful integration with an existing informatics systems, followed by a lightweight LIMS, the advantages and disadvantages of customisation and looks ahead to the next 5 years.

  • Out on a LIM: Is LIMS Selection Becoming Easier?

    There are over 200 laboratory information management systems (LIMS) vendors, so how do you find the right one? In this Pharma IQ interview John Jones, CEO of LabLynx, Inc and the Laboratory Informatics Institute, guides us through the informatics landscape with his top tips for choosing the right LIMS vendor for your laboratory, and also shares his future predictions for growth in laboratory informatics. Finally, he shares his insights on how laboratory informatics is just one disaster away from new regulation.


  • Next Generation Knowledge Extraction - ELNS Beyond Productivity Improvement

    "Setting data free.  We cannot predict how or why data will be used in the future" - Morten Meldgaard, Project Director, Chr. Hansen.

    In this exclusive Pharma IQ podcast John Trigg, Director, phaseFour Informatics and Morten Meldgaard, Project Director, Chr. Hansen A/S, discuss the possibilities for ELNs and maximising knowledge extraction from experimental data. Meldgaard shares his insights on how we can take ELNs beyond sharing knowledge to knowledge creation, and the opportunities analysis and visualisation present for the industry. Finally Trigg and Melgaard discuss the ability to preserve data over the long term and the benefits for future generations of scientists.


  • Are we in Danger of Suffering from a Data & Information Overload in Healthcare IT?

    Healthcare informatics is a discipline that is ever-changing from mobile devices, to cloud-based computing to language technology, with the rise in genomics and preventative medicine we can expect more triggers of change. In this exclusive Pharma IQ interview, Dirk Hüske-Kraus PhD, Clinical Director of the Clinical Transformation and Education Group at Philips Healthcare, speaks to Andrea Charles from Pharma IQ, about personalised medicine as the real game changer for healthcare IT, the importance of data privacy, as well as trends and realistic expectations in Big Data. Plus, Hüske-Kraus casts a spotlight on the future opportunities for healthcare informatics and the informed, empowered patient.


  • How ELNs Can Help Maximise Biopharmaceutical Lab Efficiency

    Discover first hand how Roche deployed an ELN within the biopharmaceutical area.

    This interview with Ralph Haffner, Head of Biologic Research Informatics at Roche, documents the drivers, the planning and selection phase, through to the deployment and integration of an ELN. He also comments on how the industry is progressing in creating an IT architecture, and offers his views on the potential integration of the iPad to support an ELN system.

Articles

  • Lessons Learnt: Novartis Integrate an ELN system with a Web Interface
    Raquel Dias Miranda, Application Service Manager for Novartis Pharma AG, joins Pharma IQ to discuss the upgrade of the ELN System in place at Novartis.     Pharma IQ:  How long has the ELN been established within the chemistry area at Novartis?   R Dias-Miranda: We currently use the Perkin Elmer ELN. It has been in place for the past five years and been through a couple of upgrades in the meantime due to compatibility issues with Office 2007. We’re finally moving to the new and unreleased version 12, which is compatible with Windows 7; one of the reasons why we’re doing the upgrade.   Pharma IQ: Do you face many integration problems or many issues trying to get your systems to talk to each other and how do you overcome those problems?   R Dias-Miranda: We do have a lot of legacy applications, legacy data and very old applications. It was quite an effort to migrate these and make compatible with Windows 7.  So it was quite hard
  • Will SDMS Become ELN of the Future?
        What Does The Future Hold For Electronic Lab Notebooks In 2012? Download the free 2012 ELN Global Forecast eBook now to find out! Pharma IQ Q&A: An interview with Joseph Kofman, PhD, R&D Information Systems Director, Allergan, on exploring and adopting an SDMS as an ELN generic substitute. What are some functionalities that the Scientific Data Management Systems (SDMS) bring into the laboratory workflow? SDMS has to be recognised as a generic environment that provides a receptacle functionality for any documents generated in the laboratory. It also supports the business workflows for moving documents along laboratory and QA chains. SDMS offers controlled and structured areas where documents can be compiled in the presentable formats. I would like to mention the following SDMS features that can be used in the generic ELN settings: variety of forms (Acrobat, Word, InfoPath, and Excel) with the electronic and digital signature capabilities, auto e-mail
  • The Top 10 Most Popular ELNs Stories of 2013 (So Far)
    The Top 10 Most Popular ELNs (Electronic Laboratory Notebook) Stories of 2013 Building an intelligent lab informatics system is fast becoming an intrinsic part of the long term strategy for a wide range of industries, all with one common aim -  to drive productivity and decision making based on improved data analysis. Pharma IQ looks back on some of the most read pieces on the site this year.    The Top 10 ELNs reads on www.pharma-iq.com in 2013 (so far). ELNs, Data Analytics, Knowledge Management: Trends, Challenges & Opportunities The need to effectively utilise the data and apply knowledge management is being discussed in the boardroom, but how are you reacting to these changes and how will they impact the future? Will SDMS Become ELN of the Future? Although our laboratory scientists recognise  Scientific Data Management Systems (SDMS) offering of exciting new perspectives to laboratory data management, we are definitely facing resistance from

Video

  • Find out 4 ways to revolutionize your sponsored session and generate more businessFind out 4 ways to revolutionize your sponsored session and generate more business
    Vanessa Lovatt, General Manager at IQPC presents a 4-minute seminar on how to improve audience engagement and get better results from your sponsored session. Sales tactics of the past are no longer appropriate for most businesses, and certainly most conferences. What’s more our research has shown that these types of pitches are almost completely ineffective.

    So how do you avoid falling into this trap and become one of the forward thinkers? Take just 4 minutes to find out 4 ways to revolutionize your sponsored session and ensure that you generate more leads and have better follow up meetings after your session. The seminar closes with a short interview with one of our sponsors, Rob Hijboom, Global Director, Customer Experience Management, Metrixlab, who has discovered the benefits of following the 4 golden rules.

Download the Agenda

Resource Center

Download Centre

Access the Download Centre for articles, top rated presentations and more!

Featured Content

Quick Links

IDGA

Become a Pharma IQ Member and receive our weekly newsletter!


Sponsors & Exhibitors
Media Partners